Aarhus University - Pharmaceuticals & Healthcare - Deals and Alliances Profile

 

Rating

4.2 Star Rating for report Aarhus University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
4.2 / 5 stars rating
Pages: 22
Price: $250.00

Some of our Clients

Some Research and Expert Clients

Abstract

 
Aarhus University - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
 

Description

Aarhus University (Aarhus) is a university that undertakes activities related to research, talent development, knowledge exchange and education. The university offers bachelor's degree programmes, master's degree programmes and PhD programmes in various disciplines. Its areas of academic interest comprise arts, science and technology, health and business and social sciences. Aarhus's operates through various departments in the areas of aesthetics and communication, agroecology, dentistry, economics and business, forensic medicine, law, mathematics, molecular biology and genetics, among others. The university also provides public sector consultancy services and has research collaborations with private companies and educational institutions. Aarhus is headquartered in Aarhus, Denmark. 

Report Source Information

Supplied by: Research and Experts 
Date Published: 2017-11-27 

Report: Aarhus University - Pharmaceuticals & Healthcare - Deals and Alliances Profile

 

Contents

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Aarhus University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Aarhus University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Aarhus University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Aarhus University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Aarhus University, Medical Devices Deals, 2011 to YTD 2017 9
Aarhus University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Aarhus University, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
RedHill Biopharma Enters into Research Agreement with Aarhus University 11
MipSalus Partners with Aarhus University 12
Meta-IQ Enters into Partnership with Aarhus University 13
Licensing Agreements 14
Exiqon Enters into Licensing Agreement with Aarhus University Hospital 14
Exiqon Enters into Licensing Agreement with Aarhus University Hospital 15
Aarhus University - Key Competitors 16
Aarhus University - Key Employees 17
Aarhus University - Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Government and Public Interest 19
Aug 16, 2016: Molecule prevents effect of chemotherapy 19
Product News 20
Sep 20, 2017: Characterization of a Slowly Proliferating Population of Melanoma Cells with High Metastatic Properties 20
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22
 

List of Tables

List of Tables
Aarhus University, Pharmaceuticals & Healthcare, Key Facts 2
Aarhus University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Aarhus University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Aarhus University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Aarhus University, Deals By Therapy Area, 2011 to YTD 2017 8
Aarhus University, Medical Devices Deals, 2011 to YTD 2017 9
Aarhus University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
RedHill Biopharma Enters into Research Agreement with Aarhus University 11
MipSalus Partners with Aarhus University 12
Meta-IQ Enters into Partnership with Aarhus University 13
Exiqon Enters into Licensing Agreement with Aarhus University Hospital 14
Exiqon Enters into Licensing Agreement with Aarhus University Hospital 15
Aarhus University, Key Competitors 16
Aarhus University, Key Employees 17
Aarhus University, Subsidiaries 18
 

List of Figures

List of Figures
Aarhus University, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
Aarhus University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
Aarhus University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
Aarhus University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
Aarhus University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Aarhus University, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Aarhus University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Aarhus University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Aarhus University, Medical Devices Deals, 2011 to YTD 2017 9
 

Scope


- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

 

Classification

Language Code: EN 
Region: Denmark 
Report Type: Company Reports 
Industry: Life Sciences 
Sector: Life Sciences 
Pages: 22 

Reasons to buy this report

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
 

Aarhus University - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Report 05IC-GDPH142315D has a rating of 83 percent
Figure of merit assessment for report 05IC-GDPH142315D

Relevance Rating

The Research and Experts relevance ranting consists of a set of figure of merit (FOM) values that are provided as an indication of the value of the report in the current economic environment.

These FOM values cannot take into account the reason for the clients interest in a report and therefore the client should view these FOM values only as a visual guide. The FOM scores are based on

market interest - how often the report is viewed or purchased,
elapsed time - time since the report was published,
report detail - amount of detail in the report (pages, figures, images, comments etc.) and
price - the price of the report.


Regional Information

Taxonomy

Branch ID: 1391

Taxonomy Location

The taxonomy on the left shows the ancestors of the Denmark node. This provides an insight into parent categories that may provide reports or articles that may compliment this report. The number in brackets after the node name indicates the number of reports that Research and Experts currently have in the parent category.

Clicking on a parent category will present the list of reports in the parent node in a separate window.

Denmark

Denmark has a strong but small mixed economy which is worth $355billion. Unemployment is at 7.3%. 

Main industries include petroleum and gas, iron, steel, nonferrous metals, chemicals, food processing, machinery and transportation equipment, textiles and clothing, electronics, construction, furniture and other wood products, shipbuilding and refurbishment, windmills, pharmaceuticals, medical equipment. As yet, Denmark has not adopted the euro.

Issues of concern over the Danish economy are the low productivity levels (according to the OECD the Danes spend some of the fewest hours working per annum). They also have the highest levels of personal debt in the world probably because they have the highest levels of income tax and a high cost of living. They also have issues with their education and health services which need to be addressed.

As exports of goods and services increase the Danish government expects a growth rate of 1.4% in 2014 and 1.8% in 2015.

Researchandexperts.com is a  leading source of market research on Denmark. 

Useful Links

World Bank, Doing Business in Denmark

Overview of Denmark, official website of Denmark

Denmark

Nordic Countries

Region

 

Europe

Fifty six sovereign states are listed with territory in Europe (six have limited rocognition). The 50 soverign states of Europe are Albania, Andorra, Armenia, Austria, Azerbaijan, Belarus, Belgium, Bosnia & Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark,  Estonia,  Finland, France, Georgia, Germany, Greece, Hungary, Iceland, Ireland, Italy, Kosovo, Latvia, Lithuania, Luxembourg, Macedonia, Malta, Moldova, Monaco, Montenegro, The Netherlands, Norway, Poland, Portugal, Romania, Russia, San Marino, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, Ukraine, United Kingdom, Vatican City (Holy See).

The leading economies of Europe are Germany, France, UK, Italy and Russia.
 
Research and Experts, the market intelligence platform, provides companies with access to the latest leading industry reports covering the European region. Our company reports contain the following information; company overviews, key facts, key employees, products and services, as well as financial ratios. Our industry reports are vital sources of detailed historic and forecast values for markets in Europe, segmented at category level. Research and Experts reports also provide regional analysis and analysis of the leading companies in key European markets. 

Europe

Country

Countries

 

Industry Sector Information

Taxonomy

Branch ID: 205

Taxonomy Location

The taxonomy on the left shows the ancestors of the Life Sciences node. This provides an insight into parent categories that may provide reports or articles that may compliment this report. The number in brackets after the node name indicates the number of reports that Research and Experts currently have in the parent category.

Clicking on a parent category will present the list of reports in the parent node in a separate window.

Life Sciences

The Life Sciences industry includes biotechnology, healthcare, pharmaceuticals, medical devices and diagnostics. The industry is dominated by US companies requiring considerable investment in research and development to stay competitive.  While US companies dominate this space, competition is emerging from smaller companies in Europe and Asia. 

Companies trying to stay competitive or enter new markets in life sciences consult our reports. For example, Plimsoll, in their recent review of global antibiotic manufacturers have reviewed 150 of the largest manufacturers including analysis of  ANTIBIOTICE SA, BAYER HEALTHCARE MANUFACTURING SRL and CIPLA LTD. 

Our reports are a requirement for companies looking for the best competitive intelligence in the life sciences sector providing information on market size, rankings, best trading partners and financial analysis. 

Useful Links

Analytical Life Sciences and Diagnostics Association

German Life Sciences Association

 

Life Sciences

Industry

Industries

 

 

Buy: Aarhus University - Pharmaceuticals & Healthcare - Deals and Alliances Profile

 

Item Code: 05IC-GDPH142315D

 
Licence: Single User
Price: $250.00
 
VAT: 0.0% 
Total: $250.00 

Feedback

Return to Research and Experts

Page created and rendered - Cache updated [1.39594s]

--